Seres Therapeutics Announces Key Findings from SER-109 Phase 2 Study Analyses

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/20/2026

1. TGT
2. EL
3. MRK
4. BILL
5. MRNA
6. RARE
7. LOW
8. DE
9. JKHY
10. ADI

Go back to Seres Therapeutics Announces Key Findings from SER-109 Phase 2 Study Analyses
(NASDAQ: MCRB) Delayed: 4.68 --0 (-0%)
Previous Close $4.68    52 Week High $44.51 
Open $4.68    52 Week Low $8.05 
Day High $4.68    P/E N/A 
Day Low $4.68    EPS $0.00 
Volume 815